RadNet’s $270M Gleamer Acquisition Boosts AI‑Driven Radiology, Strengthening Investor Confidence
RadNet’s $270 M AI‑radiology deal powers a cloud‑first future, boosting breast‑cancer detection by 12% and cutting false positives—CEO’s share buy confirms confidence and may steady investors amid regulatory and earnings challenges.
3 minutes to read
